Highlights
NASDAQ: CTXR       Citius Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
1.16   +0.14 (13.73%)  1.00 - 1.19  693,300

Overview

 
Avg Volume (4 weeks):883,058
4 Weeks Range:0.80 - 1.45
4 Weeks Price Volatility (%):
55.38%
52 Weeks Range:0.40 - 1.59
52 Weeks Price Volatility (%):
63.87%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. The company is primarily operating within the critical care and cancer care market segments.

  Be the first to like this.
 


 

2885  5191  592  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.79-0.38 
 FCEL 2.22-0.66 
 CHK 0.593-0.004 
 AVP 5.60-0.05 
 GE 11.37-0.29 
 EEM 45.43+0.37 
 NTRP 1.42-0.03 
 SPY 331.34+0.04 
 FXI 43.47+0.48 
 GNPX 1.89+0.74 
Partners & Brokers